Necessary criteria for the comparative evaluation of alkylating agents in clinical cancer chemotherapy.
作者信息
GELLHORN A
出版信息
Ann N Y Acad Sci. 1958 Apr 24;68(3):891-8. doi: 10.1111/j.1749-6632.1958.tb42647.x.
Abstract
摘要
相似文献
1
Necessary criteria for the comparative evaluation of alkylating agents in clinical cancer chemotherapy.
Ann N Y Acad Sci. 1958 Apr 24;68(3):891-8. doi: 10.1111/j.1749-6632.1958.tb42647.x.
2
The status of alkylating agents in clinical cancer chemotherapy.烷化剂在临床肿瘤化疗中的地位。
Ann N Y Acad Sci. 1958 Apr 24;68(3):1254-7. doi: 10.1111/j.1749-6632.1958.tb42688.x.
3
Procedures recommended for the clinical trial of alkylating agents.
Ann N Y Acad Sci. 1958 Apr 24;68(3):1246-53. doi: 10.1111/j.1749-6632.1958.tb42687.x.
4
COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. II. THERAPEUTIC ACTIVITIES OF ALKYLATING AGENTS AND REFERENCE COMPOUNDS AGAINST VARIOUS TUMOR SYSTEMS.
Cancer Chemother Rep. 1965 Jan;18:SUPPL 2:403+.
5
Cancer chemotherapy.
Med Lett Drugs Ther. 1983 Jan 7;25(626):1-8.
6
[Chemotherapy of cancer].[癌症的化疗]
Recenti Prog Med. 1970 Nov;49(5):484-506.
7
[Secondary chemotherapy in advanced ovarian cancer--new drugs].
Onkologie. 1985 Dec;8(6):410-6. doi: 10.1159/000215698.
8
Some developments in cancer chemotherapy.癌症化疗的一些进展。
Nurs Mirror. 1978 Mar 23;146(12):18-20.
9
Drugs for the cancer surgeon.癌症外科医生用药。
J R Nav Med Serv. 1969 Winter;55(3):200-23.
10
[Cancer chemotherapy: a challenge to take up].
Infirm Can. 1979 Apr;21(4):18-26.
Zotero 插件